GENNEX LABORATORIES
|
The Current P/S Ratio of GENNEX LABORATORIES is 2.70.
| Share Price | ₹16.4 | Oct 31,2025 |
| Market Cap | ₹399.1 Cr | |
| Sales-TTM | ₹147.9 Cr | TTM-Consolidated Results |
| Price/Sales | 2.70x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of GENNEX LABORATORIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹399.1 Cr] as on Oct 31,2025
(/) Sales [ ₹147.9 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.70x ]
Thus, for GENNEX LABORATORIES , the investors are currently willing to pay '2.70 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of GENNEX LABORATORIES !
The chart below summarizes the trend in P/S Ratio of GENNEX LABORATORIES over the last five years.
Historical PS (Price/Sales) ratio chart of GENNEX LABORATORIES
PS Ratio Performance Analysis for GENNEX LABORATORIES
- GENNEX LABORATORIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.69x.
- GENNEX LABORATORIES 's operated at median p/e ratio of 1.51x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, GENNEX LABORATORIES 's p/e ratio peaked in Mar2024 at 4.14x.
- GENNEX LABORATORIES 's p/e ratio hit its five-year low in Mar2020 of 0.42x.
How does GENNEX LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| GENNEX LABORATORIES | 147.9 | 2.70 | 399.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 53,777.1 | 7.54 | 405,452.0 |
| DIVIS LABORATORIES LTD | 9,652.0 | 18.55 | 179,089.0 |
| CIPLA LTD | 28,349.6 | 4.28 | 121,299.0 |
| TORRENT PHARMACEUTICALS LTD | 11,835.0 | 10.18 | 120,456.0 |
| DR REDDYS LABORATORIES LTD | 34,310.0 | 2.91 | 99,965.9 |
| MANKIND PHARMA LTD | 12,956.2 | 7.59 | 98,333.5 |
| ZYDUS LIFESCIENCES LTD | 23,607.7 | 4.15 | 98,057.5 |
| LUPIN LTD | 23,375.9 | 3.84 | 89,722.4 |
| AUROBINDO PHARMA LTD | 32,024.8 | 2.07 | 66,133.0 |
| ABBOTT INDIA LTD | 6,589.9 | 9.35 | 61,629.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs GENNEX LABORATORIES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.07x |
| Max industry PS | 18.55x |
| Median industry PS | 4.28x |
| Average industry PS | 6.65x |
You may also like the below Video Courses